Development Diligence. Novartis shall itself, or through its Affiliates or sublicensees, use Commercially Reasonable Efforts to Develop at least one Product in the Field. Subject to compliance with the foregoing, the Development of the Products shall be in Novartis’ sole discretion.
Appears in 2 contracts
Sources: Option Agreement (Quark Pharmaceuticals Inc), Option Agreement (Quark Pharmaceuticals Inc)
Development Diligence. Novartis shall itself, or through its Affiliates Affiliates, sublicensees, or sublicenseesother Third Parties, use Commercially Reasonable Efforts to Develop at least one Product [***] for each Target in the Therapeutic Field. Subject to compliance with the foregoing, the Development of the Products Product shall be in Novartis’ sole discretion.
Appears in 2 contracts
Sources: License and Collaboration Agreement (Molecular Partners Ag), License and Collaboration Agreement (Molecular Partners Ag)
Development Diligence. Novartis shall will itself, or through its Affiliates or sublicensees, use Commercially Reasonable Efforts to Develop at least one Product in the Field. Subject to compliance with the foregoing, the Development of the Products shall Product will be in Novartis’ sole discretion.
Appears in 1 contract